Check-Cap Ltd.
CHEK:NASDAQ
Check-Cap is advancing the development of C-Scan, the first and only preparation-free ingestible scanning capsule for the prevention of CRC through the detection of precancerous polyps. The patient-friendly test has the potential to increase screening adherence and reduce the overall incidence of CRC.
Streetwise Company Fact Sheet
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
